SD Silberstein

7.1k total citations · 2 hit papers
56 papers, 5.2k citations indexed

About

SD Silberstein is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, SD Silberstein has authored 56 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Psychiatry and Mental health, 28 papers in Pathology and Forensic Medicine and 25 papers in Physiology. Recurrent topics in SD Silberstein's work include Migraine and Headache Studies (45 papers), Sympathectomy and Hyperhidrosis Treatments (21 papers) and Trigeminal Neuralgia and Treatments (20 papers). SD Silberstein is often cited by papers focused on Migraine and Headache Studies (45 papers), Sympathectomy and Hyperhidrosis Treatments (21 papers) and Trigeminal Neuralgia and Treatments (20 papers). SD Silberstein collaborates with scholars based in United States, Germany and Denmark. SD Silberstein's co-authors include DW Dodick, RB Lipton, Peter J. Goadsby, SK Aurora, CC Turkel, HC Diener, RE DeGryse, Richard B. Lipton, David W. Dodick and Marcelo E. Bigal and has published in prestigious journals such as Neurology, Osteoarthritis and Cartilage and Headache The Journal of Head and Face Pain.

In The Last Decade

SD Silberstein

54 papers receiving 4.9k citations

Hit Papers

OnabotulinumtoxinA for treatment of chronic migraine: Res... 2010 2026 2015 2020 2010 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
    2010 744 citations DW Dodick, SD Silberstein et al. Cephalalgia profile →
  2. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
    2010 676 citations DW Dodick, SD Silberstein et al. Cephalalgia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SD Silberstein United States 34 4.4k 2.9k 2.3k 958 486 56 5.2k
Ninan T. Mathew United States 45 5.1k 1.2× 3.2k 1.1× 2.6k 1.1× 1.3k 1.4× 638 1.3× 103 6.1k
Jan Lewis Brandes United States 36 4.4k 1.0× 2.8k 0.9× 1.8k 0.8× 433 0.5× 473 1.0× 73 5.0k
Massimo Leone Italy 44 5.5k 1.2× 3.9k 1.3× 2.9k 1.2× 1.2k 1.3× 434 0.9× 206 6.9k
Sait Ashina United States 34 3.6k 0.8× 1.9k 0.6× 1.3k 0.5× 725 0.8× 517 1.1× 111 4.7k
Sheena K. Aurora United States 39 5.7k 1.3× 3.6k 1.2× 2.4k 1.0× 994 1.0× 469 1.0× 113 6.8k
Paul Winner United States 35 4.2k 1.0× 2.3k 0.8× 1.9k 0.8× 426 0.4× 1.1k 2.2× 111 4.8k
Seymour Diamond United States 29 4.5k 1.0× 2.6k 0.9× 1.8k 0.8× 430 0.4× 568 1.2× 160 5.4k
Patricia Pozo‐Rosich Spain 37 4.1k 0.9× 2.3k 0.8× 1.3k 0.6× 1.3k 1.3× 380 0.8× 206 5.2k
Egilius L.H. Spierings United States 35 2.8k 0.6× 1.7k 0.6× 1.6k 0.7× 353 0.4× 398 0.8× 158 4.2k
Michael Bjørn Russell Norway 39 4.1k 0.9× 2.1k 0.7× 1.6k 0.7× 529 0.6× 459 0.9× 124 5.4k

Countries citing papers authored by SD Silberstein

Since Specialization
Citations

This map shows the geographic impact of SD Silberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SD Silberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SD Silberstein more than expected).

Fields of papers citing papers by SD Silberstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SD Silberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SD Silberstein. The network helps show where SD Silberstein may publish in the future.

Co-authorship network of co-authors of SD Silberstein

This figure shows the co-authorship network connecting the top 25 collaborators of SD Silberstein. A scholar is included among the top collaborators of SD Silberstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SD Silberstein. SD Silberstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argoff, Charles E., et al.. (2013). Diclofenac submicron particle capsules demonstrate early and sustained acute pain relief in a phase 3 study in patients following bunionectomy surgery. Osteoarthritis and Cartilage. 21. S291–S291. 3 indexed citations
2.
Silberstein, SD, et al.. (2012). Preventive Antimigraine Drugs. Open Repository and Bibliography (University of Liège). 2 indexed citations
3.
Kallela, Mikko, et al.. (2009). Short-Term Frovatriptan for the Prevention of Difficult-To-Treat Menstrual Migraine Attacks. Cephalalgia. 29(11). 1133–1148. 65 indexed citations
4.
Silberstein, SD, et al.. (2008). Hemicrania Continua: Who Responds to Indomethacin?. Cephalalgia. 29(3). 300–307. 39 indexed citations
5.
Silberstein, SD, Hartmut Göbel, Rigmor Jensen, et al.. (2006). Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study. Cephalalgia. 26(7). 790–800. 112 indexed citations
6.
Ramadan, NM, SD Silberstein, KW Johnson, et al.. (2004). LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine. Cephalalgia. 24(7). 596–602. 138 indexed citations
7.
Silberstein, SD. (2004). Migraine Pathophysiology and its Clinical Implications. Cephalalgia. 24(2_suppl). 2–7. 189 indexed citations
8.
Reuter, Uwe, et al.. (2003). Placebo Adverse Events in Headache Trials: Headache as an Adverse Event of Placebo. Cephalalgia. 23(7). 496–503. 25 indexed citations
9.
Piovesan, EJ, et al.. (2003). Recurrent Extratrigeminal Stabbing and Burning Sensation with Allodynia in A Migraine Patient. Cephalalgia. 23(3). 231–234. 10 indexed citations
10.
Lipton, Richard B., SD Silberstein, Joel R. Saper, Marcelo E. Bigal, & Peter J. Goadsby. (2003). Why headache treatment fails. Neurology. 60(7). 1064–1070. 73 indexed citations
11.
Silberstein, SD & Peter J. Goadsby. (2002). Migraine: Preventive Treatment. Cephalalgia. 22(7). 491–512. 201 indexed citations
12.
Peres, Mário Fernando Prieto, et al.. (2002). Greater Occipital Nerve Blockade for Cluster Headache. Cephalalgia. 22(7). 520–522. 146 indexed citations
13.
Newman, Lawrence C., Stephen H. Landy, SD Silberstein, et al.. (2001). Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study. Headache The Journal of Head and Face Pain. 41(3). 248–256. 135 indexed citations
14.
Dodick, DW, TD Rozen, Peter J. Goadsby, & SD Silberstein. (2000). Cluster Headache. Cephalalgia. 20(9). 787–803. 108 indexed citations
15.
Silberstein, SD. (1999). Menstrual Migraine. Journal of Women s Health & Gender-Based Medicine. 8(7). 919–931. 30 indexed citations
16.
Silberstein, SD. (1998). Methysergide. Cephalalgia. 18(7). 421–435. 61 indexed citations
17.
Silberstein, SD. (1998). Comprehensive Management of Headache and Depression. Cephalalgia. 18(21 suppl). 50–55. 22 indexed citations
18.
Silberstein, SD. (1997). Preventive Treatment of Migraine. Cephalalgia. 17(2). 67–72. 55 indexed citations
19.
Silberstein, SD, R.B. Lipton, & Naomi Breslau. (1995). Migraine: Association with Personality Characteristics and Psychopathology. Cephalalgia. 15(5). 358–369. 89 indexed citations
20.
Silberstein, SD. (1993). Office management of benign headache. Postgraduate Medicine. 93(1). 223–240.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ninan T. Mathew Breakdown of academic impact, for papers by Jan Lewis Brandes Breakdown of academic impact, for papers by Massimo Leone Breakdown of academic impact, for papers by Sait Ashina Breakdown of academic impact, for papers by Sheena K. Aurora Breakdown of academic impact, for papers by Paul Winner Breakdown of academic impact, for papers by Seymour Diamond Breakdown of academic impact, for papers by Patricia Pozo‐Rosich Breakdown of academic impact, for papers by Egilius L.H. Spierings Breakdown of academic impact, for papers by Michael Bjørn Russell
Rankless by CCL
2026